Renal Association Commentary on the KDIGO (2017) Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of CKD-MBD

Overview

Journal BMC Nephrol

Publisher Biomed Central

Specialty Nephrology

Date 2018 Sep 22

PMID 30236082

Citations 12

Authors

James O Burton

David J Goldsmith

Nicki Ruddock

Rukshana Shroff

Mandy Wan

Affiliations

Soon will be listed here.

Abstract

This report comments on the relevance and utility of the recently published (2017) KDIGO Clinical Practice Guideline Update for the diagnosis, evaluation, prevention and treatment of mineral bone disease in patients with chronic kidney disease (CKD-MBD) with respect to UK clinical practice. This document replaces all previously published Renal Association guidelines on the topic.

Citing Articles

Synbiotics as a novel therapeutic approach for hyperphosphatemia and hyperparathyroidism in chronic kidney disease rats.

Anegkamol W, Bowonsomsarit W, Taweevisit M, Tumwasorn S, Thongsricome T, Kaewwongse M Sci Rep. 2025; 15(1):7493.

PMID: 40032932 PMC: 11876653. DOI: 10.1038/s41598-025-91033-9.

Multifaceted skeletal effects of sevelamer carbonate in a secondary hyperparathyroidism model.

Sharma S, Kumar S, Tomar M, Chauhan D, Sadhukhan S, Kulkarni C Endocrine. 2025; .

PMID: 39918636 DOI: 10.1007/s12020-025-04180-4.

Risk factors and clinical prediction models for osteoporosis in pre-dialysis chronic kidney disease patients.

Kuang C, Shang J, Ma M, Huang S, Yan B, Zhong Y Ren Fail. 2024; 46(2):2361802.

PMID: 38874080 PMC: 11182074. DOI: 10.1080/0886022X.2024.2361802.

Impact of Pre-Transplant Parathyroidectomy on Graft Survival: A Comparative Study of Renal Transplant Patients (2005-2015).

Tsai M, Chen M, Liou H, Lee T, Huang Y, Liu P Med Sci Monit. 2023; 29:e940959.

PMID: 37525452 PMC: 10403992. DOI: 10.12659/MSM.940959.

Vitamin D and Chronic Kidney Disease Association with Mineral and Bone Disorder: An Appraisal of Tangled Guidelines.

Bover J, Masso E, Gifre L, Alfieri C, Soler-Majoral J, Fusaro M Nutrients. 2023; 15(7).

PMID: 37049415 PMC: 10097233. DOI: 10.3390/nu15071576.

References

Oksa A, Spustova V, Krivosikova Z, Gazdikova K, Fedelesova V, Lajdova I . Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease. Kidney Blood Press Res. 2008; 31(5):322-9. DOI: 10.1159/000157177. View

Garrett G, Sardiwal S, Lamb E, Goldsmith D . PTH--a particularly tricky hormone: why measure it at all in kidney patients?. Clin J Am Soc Nephrol. 2012; 8(2):299-312. DOI: 10.2215/CJN.09580911. View

Ok E, Asci G, Bayraktaroglu S, Toz H, Ozkahya M, Yilmaz M . Reduction of Dialysate Calcium Level Reduces Progression of Coronary Artery Calcification and Improves Low Bone Turnover in Patients on Hemodialysis. J Am Soc Nephrol. 2015; 27(8):2475-86. PMC: 4978036. DOI: 10.1681/ASN.2015030268. View

Naylor K, Garg A, Zou G, Langsetmo L, Leslie W, Fraser L . Comparison of fracture risk prediction among individuals with reduced and normal kidney function. Clin J Am Soc Nephrol. 2015; 10(4):646-53. PMC: 4386249. DOI: 10.2215/CJN.06040614. View

Chue C, Townend J, Moody W, Zehnder D, Wall N, Harper L . Cardiovascular effects of sevelamer in stage 3 CKD. J Am Soc Nephrol. 2013; 24(5):842-52. PMC: 3636795. DOI: 10.1681/ASN.2012070719. View

Thadhani R, Appelbaum E, Pritchett Y, Chang Y, Wenger J, Tamez H . Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA. 2012; 307(7):674-84. DOI: 10.1001/jama.2012.120. View

Hahn D, Hodson E, Craig J . Interventions for metabolic bone disease in children with chronic kidney disease. Cochrane Database Syst Rev. 2015; (11):CD008327. PMC: 7180137. DOI: 10.1002/14651858.CD008327.pub2. View

Jamal S, Vandermeer B, Raggi P, Mendelssohn D, Chatterley T, Dorgan M . Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet. 2013; 382(9900):1268-77. DOI: 10.1016/S0140-6736(13)60897-1. View

Akaberi S, Simonsen O, Lindergard B, Nyberg G . Can DXA predict fractures in renal transplant patients?. Am J Transplant. 2008; 8(12):2647-51. DOI: 10.1111/j.1600-6143.2008.02423.x. View

10.

Coyne D, Acharya M, Qiu P, Abboud H, Batlle D, Rosansky S . Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD. Am J Kidney Dis. 2006; 47(2):263-76. DOI: 10.1053/j.ajkd.2005.10.007. View

11.

Baxter-Jones A, Faulkner R, Forwood M, Mirwald R, Bailey D . Bone mineral accrual from 8 to 30 years of age: an estimation of peak bone mass. J Bone Miner Res. 2011; 26(8):1729-39. DOI: 10.1002/jbmr.412. View

12.

Evenepoel P, Bover J, Urena Torres P . Parathyroid hormone metabolism and signaling in health and chronic kidney disease. Kidney Int. 2016; 90(6):1184-1190. DOI: 10.1016/j.kint.2016.06.041. View

13.

Spasovski G, Gelev S, Masin-Spasovska J, Selim G, Sikole A, Vanholder R . Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium. Bone. 2007; 41(4):698-703. DOI: 10.1016/j.bone.2007.06.014. View

14.

Eckardt K, Kasiske B . Foreword. Kidney Int. 2016; 76113:S1-2. DOI: 10.1038/ki.2009.188. View

15.

Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U . Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation. 2002; 106(1):100-5. DOI: 10.1161/01.cir.0000020222.63035.c0. View

16.

Lemos M, Watanabe R, Carvalho A, Jancikic A, Sanches F, Christofalo D . Effect of rosuvastatin and sevelamer on the progression of coronary artery calcification in chronic kidney disease: a pilot study. Clin Nephrol. 2013; 80(1):1-8. DOI: 10.5414/CN107630. View

17.

. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003; 42(4 Suppl 3):S1-201. View

18.

Di Iorio B, Bellasi A, Russo D . Mortality in kidney disease patients treated with phosphate binders: a randomized study. Clin J Am Soc Nephrol. 2012; 7(3):487-93. DOI: 10.2215/CJN.03820411. View

19.

Brunelli S, Sibbel S, Do T, Cooper K, Bradbury B . Facility Dialysate Calcium Practices and Clinical Outcomes Among Patients Receiving Hemodialysis: A Retrospective Observational Study. Am J Kidney Dis. 2015; 66(4):655-65. DOI: 10.1053/j.ajkd.2015.03.038. View

20.

Block G, Wheeler D, Persky M, Kestenbaum B, Ketteler M, Spiegel D . Effects of phosphate binders in moderate CKD. J Am Soc Nephrol. 2012; 23(8):1407-15. PMC: 3402292. DOI: 10.1681/ASN.2012030223. View